YimuVision, a medical visualization company, has recently completed tens of millions of yuan in angel round financing. This round of financing was led by Zhongxi Fund and followed by Oufang Angel Fund. Yatai Capital acted as the exclusive financial advisor for this round. It is reported that this round of financing will be mainly used to build a biomedical vision knowledge base and editable SaaS system for YimuVision.
Founded in 2016, Yimu Visualization team is deeply involved in the field of medical visualization, providing professional visual design products for Internet companies, enterprises, hospitals, universities, and research institutions around the world.
It is reported that YimuVision currently has more than 80 employees, more than 50% of whom are medical visual designers with medical backgrounds; in addition, it also has more than 150 professional medical consultants outside. As many as 90% of the members of the Yimu team have biomedical backgrounds. They have gathered excellent biomedical visual designers in China. Their majors cover various clinical specialties and basic disciplines such as internal medicine, surgery, gynecology, and pediatrics. They have a number of tertiary hospitals and domestic medical research Collaborative endorsement of the laboratory.
The Yimu team maintains cooperative relations with many domestic and foreign Internet companies, hospitals, universities and other institutions to provide medical visualization services, including illustration, animation, graphic design, medical image processing, 3D modeling and rendering, threejs+H5 platform multimedia interaction, etc. Since 2019, Tencent Medical Code, Baidu Health Medical Code, and Xiaohe Medical Code have reached cooperation with Yimuku, and Yimuku can serve as a medical visualization content service provider to provide medical visualization content for the above-mentioned medical science popularization platform. Starting from 2021, the medical device company Johnson & Johnson, the scientific publishing house Elsevier, and the pharmaceutical company CanSino Biologics have reached a cooperation with Yimuku. Yimuku will serve as a medical brand full-case service provider to provide brand-related customized services for the above companies .
The team’s works have been published in Nature, Cell, Science Advances, Cancer Cell, Cell Reports, Cell Stem Cell, Nano Letters, ACS Nano, Theranostics and other domestic and foreign textbooks, journals and Web portals.
It is understood that the Yimu Visual Biomedical Vision Knowledge Base is currently advancing the knowledge network of all-disciplinary medical visualization content in an orderly manner.
media reports
Arterial Network Arterial Network Entrepreneurship State
Event Tracking
- 2023-01-19 “Visible at a glance” completed tens of millions of yuan in angel round financing, led by Zhongxi Fund
- 2019-09-17Tencent and “NEJM Frontiers of Medicine” strategically cooperate to hold a frontier medical conference in November
This article is transferred from: https://readhub.cn/topic/8mH82Dv5IDC
This site is only for collection, and the copyright belongs to the original author.